WELLS FARGO & COMPANY/MN - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 57 filers reported holding ORAMED PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$11,747
-45.3%
4,501
-25.0%
0.00%
Q2 2023$21,482
+140.3%
6,001
+46.4%
0.00%
Q1 2023$8,938
-98.9%
4,100
-93.7%
0.00%
Q4 2022$778,124
+102.6%
64,682
+9.0%
0.00%
Q3 2022$384,000
+1376.9%
59,332
+964.1%
0.00%
Q2 2022$26,000
-97.7%
5,576
-95.7%
0.00%
Q1 2022$1,116,000
-14.1%
129,061
+41.9%
0.00%
Q4 2021$1,299,000
+576.6%
90,962
+939.7%
0.00%
Q3 2021$192,000
+170.4%
8,749
+66.1%
0.00%
Q2 2021$71,000
+108.8%
5,267
+57.2%
0.00%
Q1 2021$34,000
+183.3%
3,350
+17.5%
0.00%
Q4 2020$12,000
+71.4%
2,8500.0%0.00%
Q3 2020$7,000
-56.2%
2,850
-35.6%
0.00%
Q2 2020$16,000
+33.3%
4,425
+14.9%
0.00%
Q1 2020$12,000
-7.7%
3,850
+48.1%
0.00%
Q4 2019$13,000
-18.8%
2,600
-47.5%
0.00%
Q3 2019$16,000
-11.1%
4,9500.0%0.00%
Q2 2019$18,000
-51.4%
4,950
-51.5%
0.00%
Q1 2019$37,000
+19.4%
10,2000.0%0.00%
Q4 2018$31,000
-45.6%
10,200
-12.8%
0.00%
Q3 2018$57,000
-28.8%
11,700
+9.3%
0.00%
Q2 2018$80,000
+50.9%
10,700
+32.1%
0.00%
Q1 2018$53,000
-43.6%
8,100
-22.5%
0.00%
Q4 2017$94,000
-35.6%
10,450
-29.0%
0.00%
Q3 2017$146,000
+28.1%
14,7250.0%0.00%
Q2 2017$114,000
+32.6%
14,725
+4.4%
0.00%
Q1 2017$86,000
+75.5%
14,100
+76.2%
0.00%
Q4 2016$49,000
-15.5%
8,0000.0%0.00%
Q3 2016$58,000
-18.3%
8,000
-5.9%
0.00%
Q2 2016$71,000
+6.0%
8,500
-15.6%
0.00%
Q1 2016$67,000
-24.7%
10,075
-2.4%
0.00%
Q4 2015$89,000
+58.9%
10,3250.0%0.00%
Q3 2015$56,000
+47.4%
10,325
+58.8%
0.00%
Q2 2015$38,000
+171.4%
6,500
+188.9%
0.00%
Q1 2015$14,0002,250
+2150.0%
0.00%
Q4 2014$0
-100.0%
100
-75.0%
0.00%
Q2 2014$4,000
-73.3%
400
-67.6%
0.00%
Q1 2014$15,000
-28.6%
1,234
-7.5%
0.00%
Q4 2013$21,000
+162.5%
1,3340.0%0.00%
Q3 2013$8,000
-27.3%
1,334
-1.8%
0.00%
Q2 2013$11,0001,3580.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
BML Capital Management, LLC 1,355,925$2,955,9172.56%
Susquehanna International Group Ltd. 113,526$247,4870.14%
XTX Topco Ltd 151,620$330,5320.07%
Corsair Capital Management 47,256$103,0180.04%
Diametric Capital, LP 14,314$31,2050.02%
Draper Asset Management, LLC 5,320$11,5980.02%
ETF MANAGERS GROUP, LLC 68,940$150,2890.01%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$12,2670.00%
TWO SIGMA INVESTMENTS, LP 506,255$1,103,6360.00%
Apollon Wealth Management, LLC 20,000$43,6000.00%
View complete list of ORAMED PHARMACEUTICALS INC shareholders